![2020 – NANORAY-103: Phase I/II trial of NBTXR3 activated by SBRT in patients with HCC and liver metastases | Nano Publications 2020 – NANORAY-103: Phase I/II trial of NBTXR3 activated by SBRT in patients with HCC and liver metastases | Nano Publications](https://bibliography.nanobiotix.com/wp-content/uploads/2022/05/2020-nanoray-103-phase-i-ii-trial-of-nbtxr3-activated-by-sbrt-in-patients-with-hcc-and-liver-metastases.png)
2020 – NANORAY-103: Phase I/II trial of NBTXR3 activated by SBRT in patients with HCC and liver metastases | Nano Publications
High-Dose FOLFIRI plus Bevacizumab in the Treatment of Metastatic Colorectal Cancer Patients with Two Different UGT1A1 Genotypes
![Thierry Roland quitte le service funéraire de l'acteur français Jean-Pierre Cassel à l'église Saint-Eustache de Paris, France, le 26 avril 2007. Cassel est mort d'un cancer à 74 heures jeudi dernier. Photo Thierry Roland quitte le service funéraire de l'acteur français Jean-Pierre Cassel à l'église Saint-Eustache de Paris, France, le 26 avril 2007. Cassel est mort d'un cancer à 74 heures jeudi dernier. Photo](https://c8.alamy.com/compfr/2e80awj/thierry-roland-quitte-le-service-funeraire-de-l-acteur-francais-jean-pierre-cassel-a-l-eglise-saint-eustache-de-paris-france-le-26-avril-2007-cassel-est-mort-d-un-cancer-a-74-heures-jeudi-dernier-photo-de-mousse-nebinger-abacapress-com-2e80awj.jpg)
Thierry Roland quitte le service funéraire de l'acteur français Jean-Pierre Cassel à l'église Saint-Eustache de Paris, France, le 26 avril 2007. Cassel est mort d'un cancer à 74 heures jeudi dernier. Photo
![PDF) Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial – PACHA-01 (NCT02494973) PDF) Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial – PACHA-01 (NCT02494973)](https://i1.rgstatic.net/publication/326860500_Postoperative_hepatic_arterial_chemotherapy_in_high-risk_patients_as_adjuvant_treatment_after_resection_of_colorectal_liver_metastases_-_a_randomized_phase_IIIII_trial_-_PACHA-01_NCT02494973/links/5b6e3f9092851ca65054d46b/largepreview.png)
PDF) Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial – PACHA-01 (NCT02494973)
![PDF) Chemotherapy response of breast cancer depends on HER-2 status and anthracycline dose intensity in the neoadjuvant setting | Jean-Pierre Ghnassia - Academia.edu PDF) Chemotherapy response of breast cancer depends on HER-2 status and anthracycline dose intensity in the neoadjuvant setting | Jean-Pierre Ghnassia - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/43133854/mini_magick20190216-4231-14qmg9g.png?1550355201)
PDF) Chemotherapy response of breast cancer depends on HER-2 status and anthracycline dose intensity in the neoadjuvant setting | Jean-Pierre Ghnassia - Academia.edu
Synchronous Roentgenographically Occult Lung Carcinoma in Patients With Resectable Primary Lung Cancer
![Jean-Pierre POUGET | Team Leader | PhD | French Institute of Health and Medical Research | Inserm | Montpellier Cancer Research Institute IRCM | Research profile Jean-Pierre POUGET | Team Leader | PhD | French Institute of Health and Medical Research | Inserm | Montpellier Cancer Research Institute IRCM | Research profile](https://i1.rgstatic.net/ii/profile.image/669948452036624-1536739566326_Q512/Jean-Pierre-Pouget-2.jpg)
Jean-Pierre POUGET | Team Leader | PhD | French Institute of Health and Medical Research | Inserm | Montpellier Cancer Research Institute IRCM | Research profile
![PDF) Quantification of HER1, HER2 and HER3 by time-resolved Förster resonance energy transfer in FFPE triple-negative breast cancer samples PDF) Quantification of HER1, HER2 and HER3 by time-resolved Förster resonance energy transfer in FFPE triple-negative breast cancer samples](https://i1.rgstatic.net/publication/337707755_Quantification_of_HER1_HER2_and_HER3_by_time-resolved_Forster_resonance_energy_transfer_in_FFPE_triple-negative_breast_cancer_samples/links/5fd743c145851553a0b587f6/largepreview.png)
PDF) Quantification of HER1, HER2 and HER3 by time-resolved Förster resonance energy transfer in FFPE triple-negative breast cancer samples
![Frontiers | Megakaryocytes Are Regulators of the Tumor Microenvironment and Malignant Hematopoietic Progenitor Cells in Myelofibrosis Frontiers | Megakaryocytes Are Regulators of the Tumor Microenvironment and Malignant Hematopoietic Progenitor Cells in Myelofibrosis](https://www.frontiersin.org/files/Articles/906698/fonc-12-906698-HTML/image_m/fonc-12-906698-g001.jpg)
Frontiers | Megakaryocytes Are Regulators of the Tumor Microenvironment and Malignant Hematopoietic Progenitor Cells in Myelofibrosis
![Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest) – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest) – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on](https://cyberleninka.org/viewer_images/4368/f/1.png)